• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

 India’s NPPA cuts prices on drug-eluting stents by nearly 8%

February 12, 2018 By Fink Densford

India's National Pharmaceutical Pricing Authority

India’s National Pharmaceutical Pricing Authority cut prices on stents yet again, dropping the cost of certain stents by about 7.6%, according to a Reuters report.

This time, the prices on drug releasing stents were cut from approximately $469.60 (INR ₹30,180) to $433.82 (INR ₹27,890), according to the report.

The new price cap comes as somewhat of a surprise, as previous discussions between major players, industry groups and India’s NPPA indicated a willingness to revisit those price caps this February, with many assuming the caps would increase.

“This wasn’t expected. Industry discussions with the government had created an expectation that the prices would be increased for some stent varieties,” Indian industry lobby group FICCI medical device forum chair Probir Das said, according to Reuters.

The NPPA capped prices for drug-eluting stents and bioresorbable scaffolds last February, while also cutting the prices for all coronary stents by as much as 85%. The move was largely criticized by companies within the medical device industry.

Earlier this month, Indian medical device makers and trade associations voiced their opposition to price caps on stents and other devices imposed by India’s NPPA.

Filed Under: Business/Financial News, Featured, Stents Tagged With: Indian National Pharmaceutical Pricing Authority (NPPA)

IN CASE YOU MISSED IT

  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen
  • BD files patent infringement lawsuit against Baxter over infusion pump tech

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS